Medtronic plc (NYSE:MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart ...

Please provide your email address to receive an email when new articles are posted on . Medtronic recalled ICDs and CRT-Ds with a glassed feedthrough made after Oct. 13, 2017 due to risk for low- or ...

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in ...

CHICAGO, July 20 (Reuters) - Medtronic Inc has agreed to pay more than $75 million to settle lawsuits claiming it hid defects in its implantable cardioverter defibrillators, better known as ICDs, ...

DUBLIN and NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced longer-term follow-up results of its investigational EV ICD™ System, ...

CHICAGO, Nov 19 (Reuters) - Medtronic Inc. on Monday said quarterly net earnings fell 2 percent from a year ago after its decision to stop selling a faulty component used with its implantable heart ...

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

Medtronic has secured an FDA green light for a new type of implantable cardioverter-defibrillator that the medtech giant describes as the first of its kind. Unlike other ICDs that are wired into ...

Medtronic MDT recently declared the findings of its investigational Extravascular Implantable Cardioverter–Defibrillator (EV ICD) Study. These were presented as late-breaking science at Heart Rhythm ...